This announcement is a separate document:
啓明醫療-B：自願性公告-球擴幹瓣TAVR產品VENUS VITAE成功完成全球首兩例臨床應用
Venus Medtech (Hangzhou) Inc.: VOLUNTARY ANNOUNCEMENT-VENUS VITAE, BALLOON-EXPANDABLE DRY TISSUE TAVR SYSTEM SUCCESSFULLY COMPLETED THE FIRST TWO IMPLANTATIONS IN THE FIM CLINICAL TRIAL
Dec 20, 2021 08:00
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Risk Disclaimer
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
Got it
Statement
This page is machine-translated. Futubull tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation.